-
When an Alzheimer’s diagnosis happens, a wave of people are affected, and for many that means becoming a caregiver for loved ones.
-
Border counties in Texas have some of the highest Alzheimer’s diagnosis rates in the nation, with rates ranging from 13% to 18% of people aged 65 and over.
-
NPR's A Martinez talks to Mario Tapia, founder of the Latino Center on Aging, and Maria Aranda of the USC Edward R. Roybal Institute on Aging, about quality care issues once a diagnosis is made.
-
Harvard Law School professor and noted defense attorney Charles Ogletree has died at age 70.
-
Some literature points to pollution and other environmental factors as putting residents at higher risk for the disease, but researchers are exploring other potential causes.
-
The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.
-
Some are calling it the Kim Kardashian weight loss drug. Ozempic related videos have more than 1 billion views on TikTok. The medication is taken to help control blood sugar levels in type two diabetes, and it has taken off for an off-label use — as a treatment for obesity. Now, Ozempic is being studied for yet another potential use — as a treatment for Alzheimer’s disease.
-
Excess belly fat in midlife is linked to genes that may increase a person’s risk of developing Alzheimer's disease later in life.
-
The drug, lecanemab, was proven to moderately slow the disease in early stages. It also comes with the potential for some serious side effects, such as brain bleeding and brain inflammation.
-
The cryo-EM enables researchers to create 3-D models of individual proteins from thousands of images. This betters their understanding of how to target them for drug treatments.